Walleye Trading
ANAB icon

Walleye Trading’s AnaptysBio ANAB Stock Holding History

Walleye Trading’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,100
Closed -$245K – 3937
2019
Q4 		$245K Buy
+15,100
New +$357K ﹤0.01% 2999
2019
Q2 		– Sell
-5,000
Closed -$365K – 3988
2019
Q1 		$365K Buy
+5,000
New +$345K ﹤0.01% 2525

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Walleye Trading's ANAB Position: Q4 2020 in Review

Walleye Trading sold out of AnaptysBio (ANAB) in Q4 2020, closing a stake of 10,500 shares — an estimated $155K sold.

Walleye Trading first reported a position in ANAB in Q1 2019 and held it in 4 quarters. The position peaked at $310K in Q2 2019. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

  • Walleye Trading reported no remaining AnaptysBio position as of Q4 2020 after selling out during the quarter.
  • Walleye Trading sold 10,500 AnaptysBio shares in Q4 2020, an estimated $155K.
  • Walleye Trading first reported a position in AnaptysBio in Q1 2019 and held it in 4 quarters.
  • Walleye Trading's AnaptysBio position peaked at $310K in Q2 2019.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.